Skip to content

Medical-device intelligence

DiaSorin Molecular LLC: FDA clearances and recalls

Research DiaSorin Molecular LLC in public FDA records: applicant and recalling-firm names, product codes, clearance history, and recall records.

Names and coverage

This profile groups matching applicant and recalling-firm names found in covered FDA records. It does not imply a complete corporate family, current ownership, or every product marketed under a brand.

Names observed in the source

Capitalization and punctuation variants are normalized. Customer-entered watchlist aliases remain private.

Product codes in this company’s records

Record activity in this scope

13 clearance records and 8 recall records in the covered releases, across 1 source company names and 12 product codes. Dated history runs from Mar 14, 2018 to Jun 15, 2026.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202510
November 202500
December 202510
January 202600
February 202600
March 202600
April 202600
May 202600
June 202610
July 202600
August 202600
September 202600
October 202600

Product codes represented

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

21 matching records
Device / recordCompany in FDA recordSourceSource date
LIAISON NES Group A Strep; LIAISON NES Group A Strep Control Swab KitK260333 · PGXDiasorin Molecular, LLC510(k)Jun 15, 2026FDA decision date
LIAISON NES FLU A/B, RSV & COVID-19K251978 · QOFDiasorin Molecular, LLC510(k)Dec 23, 2025FDA decision date
Simplexa™ COVID-19/ Flu A/B & RSV Direct (MOL4450); Simplexa™ COVID-19/ Flu A/B & RSV Positive Control Pack (MOL4460)K252387 · QOFDiasorin Molecular, LLC510(k)Oct 30, 2025FDA decision date
Simplexa Direct Amplification Disc Kit, Rx Only, IVD The Simplexa Direct Amplification Disc Kit, REF: MOL1455 is 1 box containing 3 Direct Ampli…Z-2153-2023 · OOIDiaSorin Molecular LLCRecallJul 18, 2023FDA classification date
Simplexa COVID-19 & Flu A/B DirectK220963 · QOFDiasorin Molecular, LLC510(k)Mar 17, 2023FDA decision date
Simplexa COVID-19 Direct, REF: MOL4150; including Reaction Mix, REF: MOL4150; with previous assay definition v2Z-1209-2023 · QJRDiaSorin Molecular LLCRecallMar 3, 2023FDA classification date
Simplexa Flu A/B & RSV Direct Gen II, REF: MOL2655; including Reaction Mix REF: MOL2656; with previous assay definition v5.Z-1210-2023 · OCCDiaSorin Molecular LLCRecallMar 3, 2023FDA classification date
Simplexa Congenital CMV Direct and Simplexa Congenital CMV Positive Control PackK202755 · QDZDiasorin Molecular, LLC510(k)Nov 5, 2022FDA decision date
Simplexa COVID-19 DirectK212147 · QQXDiasorin Molecular, LLC510(k)Sep 13, 2022FDA decision date
Simplexa Direct Amplification Disc Kit, Product Kit Code MOL1455Z-0457-2022 · OOIDiaSorin Molecular LLCRecallJan 5, 2022FDA record creation date
SIMPLEXA COVID-19 Positive Control Pack, REF MOL4160, IVD, Rx Only, UDI: (01) 20816101027051Z-0162-2022 · QJRDiaSorin Molecular LLCRecallOct 21, 2021FDA record creation date
Simplexa Flu A/B & RSV Direct Gen II, Simplexa Flu A/B & RSV Positive Control PackK201505 · OCCDiasorin Molecular, LLC510(k)Aug 22, 2020FDA decision date
MOL2150 Simplexa HSV 1&2 Direct -CSF -Genital Swab -Cutaneous / Mucocutaneous Swabs Product Usage: is intended for use on the LIAISON MDX instrum…Z-2547-2020 · OQODiaSorin Molecular LLCRecallJul 10, 2020FDA classification date
MOL3650 Simplexa VZV Direct - Product Usage: is intended for use on the LIAISON MDX instrument for the qualitative detection of varicella-zoster …Z-2548-2020 · PLODiaSorin Molecular LLCRecallJul 10, 2020FDA classification date
MOL3655 Simplexa VZV Swab Direct - Product Usage: is intended for use on the LIAISON MDX instrument for the qualitative detection of varicella-zo…Z-2549-2020 · PGIDiaSorin Molecular LLCRecallJul 10, 2020FDA classification date
Simplexa VZV Swab Direct, Simplexa VZV Positive Control PackK192376 · PGIDiasorin Molecular, LLC510(k)Nov 26, 2019FDA decision date
Simplexa VZV Direct, Simplexa VZV Positive Control PackK190219 · PLODiasorin Molecular, LLC510(k)May 13, 2019FDA decision date
Simplexa Bordetella Direct, Simplexa Bordetella Positive Control PackK183223 · OZZDiasorin Molecular, LLC510(k)Dec 19, 2018FDA decision date
Simplexa GBS Direct, Simplexa GBS Positive Control PackK182467 · NJRDiasorin Molecular, LLC510(k)Nov 7, 2018FDA decision date
Simplexa Bordetella Direct, Simplexa Bordetella Positive Control PackK173498 · OZZDiasorin Molecular, LLC510(k)Aug 13, 2018FDA decision date
Simplexa HSV 1 & 2 Direct, Simplexa HSV 1 & 2 Positive Control PackK173798 · PGIDiasorin Molecular, LLC510(k)Mar 14, 2018FDA decision date

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗